Address
Curetis GmbH
Max-Eyth-Str. 42
71088 Holzgerlingen
Germany
Contact
Lisa Schneckenburger07031 / 4919510
contact@curetis.com
Website
Unyvero A50 System – Molecular Diagnostic Platform
Fast & Simple Syndromic Testing for Severe Infections – Improving Patient Outcomes
The Unyvero A50 System is a syndromic testing platform for fast diagnosis of severe infectious diseases. The system uses powerful multiplex PCR technology to detect a wide variety of microorganisms and antibiotic resistance markers within 4-5 hours
Under 2 minutes hands-on time, 4-5 hours to results, simple-automated, direct from specimen, detect microorganisms & antibiotic resistance markers
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Viruses
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Marketed product
- Research
- Development
- Validation
- Market entry
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Joint Venture
- Sell
- Outsource
Funding organisation:
Infectious disease area:
Geographic origin:
Companies looking for a multiplex PCR platform, AMR data intelligence for diagnostics
Curetis N.V.’s goal is to become a leading provider of innovative solutions for molecular diagnostics platforms combining with AMR data intelligence.
Curetis’ subsidiary Ares Genetics GmbH offers next-generation solutions for infectious disease diagnostics. The ARESdb Platform one of the most comprehensive databases worldwide on genetics of antimicrobial resistances with advanced bioinformatics
